NASDAQ OMX

Zinpro Corporation Launches Zinpro Discovery Foundation

Dela

Its mission: to discover, research, or develop solutions to improve human and animal wellness

EDEN PRAIRIE, Minn., May 31, 2017 (GLOBE NEWSWIRE) -- Zinpro Corporation has announced the launch of the Zinpro Discovery Foundation, a U.S.-tax-exempt 501(c) (3) nonprofit organization whose mission is to discover, research, or develop solutions to improve human and animal wellness across the globe.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/3a52721d-7a4c-4be7-b0bd-7380090f7406

"Zinpro Corporation pioneered the research and development of Performance Minerals® more than 45 years ago," says William Scrimgeour, president and COO. "Over the years, our many nutritional and business solutions have resulted in significant improvements in animal wellness and performance. However, our global leadership in animal mineral nutrition also comes with the responsibility to ensure our research is used to benefit society as much as possible. With this goal in mind, we have collaborated with leaders outside Zinpro to create the Zinpro Discovery Foundation."

Nutritionists have long known that trace mineral nutrition is essential to health for both humans and animals. For example, zinc deficiency negatively affects up to 2 billion people worldwide.1 For so many people across the globe, the difference between being healthy and unhealthy lies in only a few milligrams of zinc. The multiple systemic effects from zinc deficiency include growth retardation, weight loss, infertility, hair loss, mental and emotional disorder, impaired immune function and skin lesions.

Zinc is just one essential trace mineral that shows benefits when supplemented to both animal and human diets. Other essential trace minerals, such as copper, cobalt, manganese, iron, chromium, selenium and iodine, also play key roles that benefit animal and human health.

"Since our research in animal nutrition has great potential to pave the way for breakthroughs in human health, we started a nonprofit organization to make that possible, and the Zinpro Discovery Foundation is the culmination of our efforts," Scrimgeour says.

The Zinpro Discovery Foundation welcomes donations to help raise awareness and knowledge about trace mineral deficiencies and how to improve human and animal wellness. Educational and research grants are allocated by a board of directors. The donation goal for 2017 is $1 million (USD) in educational and research grants.

Grants are available to researchers and organizations through an application process that starts online at zinprodiscoveryfoundation.org. Details of the request include how a researcher or an organization would spend the funds if the grant is received. Requests are evaluated based on the applicant's stated problem statements and project goals.

To obtain additional information, including regular updates on active grants and recent donations, check online at zinprodiscoveryfoundation.org.

1. Data are based on the composite nutrient composition database, IZINCG physiological requirements and the Miller Equation to estimate zinc absorption and an assumed 25% inter-individual variation in zinc intake. Data are for the 2005 time frame (2003-2007). To confirm the prevalence of zinc deficiency, it is recommended to assess plasma zinc concentration and/or dietary zinc intake in countries identified at high risk of zinc deficiency based on a high stunting prevalence or high prevalence of dietary zinc availability (http://www.izincg.org/).

About Zinpro Corporation

More than 45 years ago, Zinpro Corporation pioneered the research and development of Performance Minerals®. As a family-owned, privately-held company, Zinpro Corporation's steady growth has come as a result of quality products, quality people and a focus on one thing: performance trace minerals for exceptional animal nutrition. Today, the company has regional sales offices located in nine countries and markets its products in more than 70 countries worldwide. For more information, visit  zinpro.com , or call +1 952-983-4000.

Performance Minerals® is a registered trademark of Zinpro Corporation. ©2017 Zinpro Corp. All rights reserved.

For more information, contact:
John Pocock
Corporate Communications Specialist
Zinpro Corporation
+1 952-983-3937
jpocock@zinpro.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Zinpro Corporation via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Skriv in din e-postadress så får du ett mejl när vi har något nytt att berätta.

Senaste pressmeddelandena från NASDAQ OMX

CP Kelco Appoints Didier Viala as New President16.10.2017 15:00Pressmeddelande

ATLANTA, Oct. 16, 2017 (GLOBE NEWSWIRE) -- CP Kelco, a leading global producer of specialty hydrocolloid solutions, announced today that Didier Viala has been appointed President, effective October 1, 2017. Viala replaces Donald Rubright, who served as CP Kelco President since 2006 and will retire at the end of 2017. Viala has also joined the CP Kelco Board of Directors. "As a market leader supplying high-quality hydrocolloid products for a range of foods and beverages, consumer products and industrial applications, CP Kelco will continue to invest in capacity additions, new product and applications development, strategic raw material sourcing, quality and safety management, and sustainability initiatives to support our customers' innovation efforts and growth strategies," Viala said. Over the course of more than 25 years with CP Kelco and its predecessor companies, Viala held leadership roles across a broad spectrum of critical areas, including innovat

LogicBio Therapeutics to Present Preclinical Data at European Society of Gene & Cell Therapy 25th Anniversary Congress in Berlin16.10.2017 15:00Pressmeddelande

· Company co-founder Professor Adi Barzel, Ph.D., to present new proof-of-concept efficacy data CAMBRIDGE, Massachusetts, Oct. 16, 2017 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc., a gene-therapy company with a mission to develop cures for early-onset life-threatening diseases, announced today that its company co-founder, Dr. Adi Barzel, will present new data from its genome-editing platform during the 25th Annual European Society of Gene & Cell Therapy (ESGCT) Congress in two presentations this Wednesday in Berlin, Germany. The ESGCT will be held from October 17-20, 2017, at the bcc Berlin. Dr. Barzel will present data in multiple animal models of disease demonstrating the extended therapeutic potential of LogicBio's proprietary GeneRide(TM) platform technology. The GeneRide technology harnesses the natural power of homologous recombination to enable precise, site-specific in vivo genome editing to deliver therapeutic genetic material without th

Invitation to presentation of LeoVegas third quarter 201716.10.2017 14:35Pressmeddelande

LeoVegas interim report for the third quarter 2017 will be published at 08:00 CET on October 25, 2017. A webcast telephone conference will be held at 09:00 CET the same day, where Gustaf Hagman, CEO and President, and Viktor Fritzén, CFO, will present the results for the third quarter 2017. A possibility will be given to ask questions via the webcast and follow the presentation live. The webcast will be accessible at: https://edge.media-server.com/m6/p/4pk3b55e                   To participate in the conference call by phone, please call one of the following numbers: SE: +46 (0) 8 5352 6408 UK: +44 (0) 20 3427 1914 US: + 1646 254 3364 Confirmation code: 35 35 667          The webcast, which afterwards also will be

Inbjudan till presentation av LeoVegas kvartalsrapport för tredje kvartalet 201716.10.2017 14:35Pressmeddelande

LeoVegas kvartalsrapport för det tredje kvartalet 2017 kommer att publiceras klockan 08:00 den 25 oktober 2017. En webbsänd telefonkonferens kommer att hållas klockan 09:00 samma dag där Gustaf Hagman, VD och koncernchef samt Viktor Fritzén, CFO, presenterar resultatet för det tredje kvartalet 2017. Det kommer att finnas möjlighet att ställa frågor via webbsändningen där även presentationsmaterialet går att följa. Webbsändningen nås på adressen: https://edge.media-server.com/m6/p/4pk3b55e För att delta i telefonkonferensen via telefon, vänligen ring in på något av följande nummer: SE: +46 (0) 8 5352 6408 UK: +44 (0) 20 3427 1914 US: + 1646 254 3364 Bekräftelsekod: 35 35 667 Webbsändningen, som även kan ses i efterhand, och pres

Concurrent Enters Definitive Agreement to Sell Content Delivery & Storage Business to Vecima Networks for $29 Million16.10.2017 14:00Pressmeddelande

Proposed Transaction Expected to Result in Debt Free Balance Sheet with $67 Million in Pro Forma Working Capital ATLANTA, Oct. 16, 2017 (GLOBE NEWSWIRE) -- Concurrent Computer Corporation (NASDAQ:CCUR) has entered into a definitive agreement to sell all of the assets of its Content Delivery & Storage Business to Vecima Networks Inc. (TSX:VCM) for a base purchase price of $29 million, subject to adjustment for normalized net working capital.  Headquartered in Victoria, British Columbia, Vecima is a leading designer and manufacturer of innovative network technology solutions. The proposed transaction, which has been approved by the Board of Directors of both companies, is subject to various terms and conditions including stockholder approval from Concurrent. "Vecima believes that the rapid growth in IPTV delivery across both MVPD private CDNs and OTT providers will continue to accelerate.  Concurrent is a recognized leader in storing, protec

Telefonica Deploys ASSIA's GPON Expresse® Solution to optimize Fiber Broadband Performance16.10.2017 14:00Pressmeddelande

REDWOOD CITY, Calif., Oct. 16, 2017 (GLOBE NEWSWIRE) -- Adaptive Spectrum and Signal Alignment, Inc. (ASSIA®). ASSIA and Telefonica announce widespread deployment of ASSIA's GPON Expresse® software across countries in South America: Argentina, Brazil, Chile, Colombia and Peru. GPON Expresse manages gigabit optical broadband networks with diagnostics for improved network performance and service delivery to Telefonica's fiber-based subscribers. GPON Expresse adds to the suite of ASSIA software products currently deployed at Telefonica in Latin America: DSL Expresse® for diagnostics and optimization of high speed DSL networks, and ClearView® for precise network analysis and recommendations for customer care agents and field technicians.  With the GPON Expresse deployment, Telefonica can now benefit from ClearView support across both copper and fiber networks.  By also incorporating ClearView support for Wi-Fi, operators can have complete end-to-end management across their ac

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum